Filing Flows › Stryker (SYK) › Q2 2026
Stryker (SYK) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 31, 2026
Stryker (SYK) reported revenue of $6.6B for the second quarter 2026 (Q2 2026), +9% from a year earlier and +9% from the quarter before. Operating margin was 25.2%, net earnings $1.3B (19.4% of revenue).
Stryker, Q2 2026: revenue $6.6B (+9% year over year), operating margin 25.2%, net earnings $1.3B, operating cash flow $1.3B. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.6B | +9% | +9% |
| Gross profit | $4.5B | +18% | +17% |
| Operating profit | $1.7B | +77% | +49% |
| Net earnings | $1.3B | +71% | +44% |
| Operating cash flow | $1.3B | +117% | +14% |
| Free cash flow | $1.1B | +155% | +14% |
What changed
Revenue was $6.6B in Q2 2026, up 9% year over year and up 9% from the previous quarter. MedSurg and Neurotechnology: was the largest line at 55% of revenue. MedSurg and Neurotechnology: added $0.32B year over year (up 10%), 56% of the total change.
Gross margin was 68.3%, up 4.5 points from Q2 2025. Operating profit was $1.7B, a 25.2% margin (up 6.7 points year over year). Of the extra revenue versus Q2 2025, 96% reached operating profit, above the 18% margin then. Operating expenses grew 4% against revenue growth of 9%. Net earnings were $1.3B, up 44% year over year. The effective tax rate was 18.4%.
Operating cash flow was $1.3B (up 14% year over year), 99% of net earnings. Non-cash charges added back $0.40B of depreciation and amortization and $0.05B of share-based compensation. Working capital and other items used $0.47B. Capital expenditures of $0.20B left free cash flow of $1.1B.
Questions
What was Stryker's revenue in the second quarter 2026?
Stryker (SYK) reported revenue of $6.6B for the second quarter 2026 (Q2 2026), +9% from a year earlier and +9% from the quarter before.
Was Stryker profitable in the second quarter 2026?
Operating profit was $1.7B (25.2% of revenue) and net earnings $1.3B.
Source: Stryker 10-Q on SEC EDGAR.